SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045315
Filing Date
2019-08-12
Accepted
2019-08-12 16:21:45
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10394_110q.htm 10-Q 816210
2 EX-31.1 a19-10394_1ex31d1.htm EX-31.1 9684
3 EX-31.2 a19-10394_1ex31d2.htm EX-31.2 9697
4 EX-32.1 a19-10394_1ex32d1.htm EX-32.1 5929
5 EX-32.2 a19-10394_1ex32d2.htm EX-32.2 5909
  Complete submission text file 0001104659-19-045315.txt   4254318

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ards-20190630.xml EX-101.INS 826502
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ards-20190630.xsd EX-101.SCH 42946
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ards-20190630_cal.xml EX-101.CAL 36020
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ards-20190630_def.xml EX-101.DEF 155932
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ards-20190630_lab.xml EX-101.LAB 380483
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ards-20190630_pre.xml EX-101.PRE 291578
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 191016794
SIC: 2834 Pharmaceutical Preparations